Mitchel Fernando

759 total citations
8 papers, 19 citations indexed

About

Mitchel Fernando is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mitchel Fernando has authored 8 papers receiving a total of 19 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Mitchel Fernando's work include Sarcoma Diagnosis and Treatment (3 papers), CAR-T cell therapy research (2 papers) and Colorectal Cancer Screening and Detection (2 papers). Mitchel Fernando is often cited by papers focused on Sarcoma Diagnosis and Treatment (3 papers), CAR-T cell therapy research (2 papers) and Colorectal Cancer Screening and Detection (2 papers). Mitchel Fernando collaborates with scholars based in United States. Mitchel Fernando's co-authors include Fred A. Luchette, Sant P. Chawla, Zaid M. Abdelsattar, Doris Quon, Simon Park, Raymond A. Verm, Marshall S. Baker, Erlinda M. Gordon, Kevin Brown and Neal Shiv Chawla and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Surgery and Journal of the American College of Surgeons.

In The Last Decade

Mitchel Fernando

8 papers receiving 19 citations

Peers

Mitchel Fernando
Andrew Wight United Kingdom
Caroline Dobeson United Kingdom
Douglas B. Johnson United States
Lauren Gunasti United States
Emine Hatipoglu United Kingdom
Mitchel Fernando
Citations per year, relative to Mitchel Fernando Mitchel Fernando (= 1×) peers Yurii Ostapenko

Countries citing papers authored by Mitchel Fernando

Since Specialization
Citations

This map shows the geographic impact of Mitchel Fernando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchel Fernando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchel Fernando more than expected).

Fields of papers citing papers by Mitchel Fernando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchel Fernando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchel Fernando. The network helps show where Mitchel Fernando may publish in the future.

Co-authorship network of co-authors of Mitchel Fernando

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchel Fernando. A scholar is included among the top collaborators of Mitchel Fernando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchel Fernando. Mitchel Fernando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Fernando, Mitchel, et al.. (2025). Effects of preoperative glucagon-like peptide-1 receptor agonist therapy on weight loss following bariatric surgery. Surgical Endoscopy. 39(7). 4545–4550. 1 indexed citations
2.
Fernando, Mitchel, Simon Park, Raymond A. Verm, et al.. (2024). Locally Advanced Adenocarcinoma of the Esophagus: Is Esophagectomy Associated with Improved Overall Survival?. Journal of the American College of Surgeons. 239(1). 68–75. 1 indexed citations
3.
Park, Simon, Raymond A. Verm, Zaid M. Abdelsattar, et al.. (2023). Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?. Surgery. 175(3). 695–703. 3 indexed citations
4.
Park, Simon, Raymond A. Verm, Zaid M. Abdelsattar, et al.. (2023). Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?. The American Journal of Surgery. 230. 63–67. 1 indexed citations
5.
Baker, Marshall S., et al.. (2023). Association between COVID-19 diagnosis and postoperative outcomes in sleeve gastrectomy and Roux-en-Y gastric bypass: A national cohort study. The American Journal of Surgery. 230. 43–46. 2 indexed citations
6.
Chawla, Sant P., et al.. (2022). GALLANT: A phase 2 study using metronomic gemcitabine, doxorubicin, nivolumab, and docetaxel as second/third-line therapy for advanced sarcoma (NCT04535713).. Journal of Clinical Oncology. 40(16_suppl). 11518–11518. 2 indexed citations
7.
Gordon, Erlinda M., et al.. (2022). Five-year results of a phase 2 trial using ipilimumab (I), nivolumab (N), and trabectedin (T) for previously untreated advanced soft tissue sarcoma (NCT03138161).. Journal of Clinical Oncology. 40(16_suppl). 11573–11573. 4 indexed citations
8.
Chawla, Neal Shiv, Jonathan Dang, Mitchel Fernando, et al.. (2021). A phase 2 study of talimogene laherparepvec, nivolumab, and trabectedin (TNT) in advanced sarcoma.. Journal of Clinical Oncology. 39(15_suppl). 11567–11567. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026